Gilbert-McClain L I, Verin A D, Shi S, Irwin R P, Garcia J G
Department of Medicine, Indiana University School of Medicine, Richard L. Roudebush Veterans Administration Medical Center, Indianapolis 46202, USA.
J Cell Biochem. 1998 Jul 1;70(1):141-55. doi: 10.1002/(sici)1097-4644(19980701)70:1<141::aid-jcb14>3.0.co;2-s.
The involvement of tyrosine protein phosphorylation in the regulation of endothelial cell (EC) contraction and barrier function is poorly understood. We have previously shown that myosin light chain (MLC) phosphorylation catalyzed by a novel 214 kDa EC myosin light chain kinase (MLCK) isoform is a key event in EC contraction and barrier dysfunction [Garcia et al. (1995): J Cell Physiol 163:510-522; Garcia et al. (1997): Am J Respir Cell Mol Biol 16:487-491]. In this study, we tested the hypothesis that tyrosine phosphatases participate in the regulation of EC contraction and barrier function via modulation of MLCK activity. The tyrosine phosphatase inhibitor, sodium orthovanadate (vanadate), significantly decreased electrical resistance across bovine EC monolayers and increased albumin permeability consistent with EC barrier impairment. Vanadate significantly increased EC MLC phosphorylation in a time-dependent manner (maximal increase observed at 10 min) and augmented both the MLC phosphorylation and permeability responses produced by thrombin, an agonist which rapidly increases tyrosine kinase activities. The vanadate-mediated increase in MLC phosphorylation was not associated with alterations in either phosphorylase A Ser/Thr phosphatase activities or in cytosolic [Ca2+] but was strongly associated with significant increases in EC MLCK phosphotyrosine content. These data suggest that tyrosine phosphatase activities may participate in EC contractile and barrier responses via the regulation of the tyrosine phosphorylation status of EC MLCK.
酪氨酸蛋白磷酸化在调节内皮细胞(EC)收缩和屏障功能中的作用尚不清楚。我们之前已经表明,由一种新型的214 kDa内皮细胞肌球蛋白轻链激酶(MLCK)同工型催化的肌球蛋白轻链(MLC)磷酸化是内皮细胞收缩和屏障功能障碍的关键事件[加西亚等人(1995年):《细胞生理学杂志》163:510 - 522;加西亚等人(1997年):《美国呼吸细胞与分子生物学杂志》16:487 - 491]。在本研究中,我们检验了这样一个假设,即酪氨酸磷酸酶通过调节MLCK活性参与内皮细胞收缩和屏障功能的调节。酪氨酸磷酸酶抑制剂原钒酸钠(钒酸盐)显著降低了牛内皮细胞单层的电阻,并增加了白蛋白通透性,这与内皮细胞屏障受损一致。钒酸盐以时间依赖性方式显著增加内皮细胞MLC磷酸化(在10分钟时观察到最大增加),并增强了凝血酶产生的MLC磷酸化和通透性反应,凝血酶是一种能迅速增加酪氨酸激酶活性的激动剂。钒酸盐介导的MLC磷酸化增加与磷酸化酶A丝氨酸/苏氨酸磷酸酶活性或胞质[Ca2 +]的改变无关,但与内皮细胞MLCK磷酸酪氨酸含量的显著增加密切相关。这些数据表明,酪氨酸磷酸酶活性可能通过调节内皮细胞MLCK的酪氨酸磷酸化状态参与内皮细胞的收缩和屏障反应。